We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APYX icon
4676
Apyx Medical
APYX
$173M
$6K ﹤0.01%
+546
New +$5.41K
CLMT icon
4677
Calumet Specialty Products
CLMT
$3.85B
$6K ﹤0.01%
809
DMAC icon
4678
DiaMedica Therapeutics
DMAC
$342M
$6K ﹤0.01%
1,408
-2,004
-59% -$16.4K
FHI icon
4679
Federated Hermes
FHI
$4.55B
$6K ﹤0.01%
178
-132,737
-100% -$4.23M
GBR icon
4680
New Concept Energy
GBR
$3.42M
$6K ﹤0.01%
1,078
+900
+506% +$4.25K
IGRO icon
4681
iShares International Dividend Growth ETF
IGRO
$1.3B
$6K ﹤0.01%
84
INDL icon
4682
Direxion Daily MSCI India Bull 2X ETF
INDL
$57.2M
$6K ﹤0.01%
+115
New +$5.57K
ING icon
4683
ING
ING
$99.8B
$6K ﹤0.01%
434
NTIC icon
4684
Northern Technologies International Corp
NTIC
$76.2M
$6K ﹤0.01%
324
+237
+272% +$3.83K
PID icon
4685
Invesco International Dividend Achievers ETF
PID
$926M
$6K ﹤0.01%
+347
New +$6.13K
PIE icon
4686
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$237M
$6K ﹤0.01%
+206
New +$5.22K
PNRG icon
4687
PrimeEnergy Resources
PNRG
$298M
$6K ﹤0.01%
115
-319
-74% -$14.5K
DMK
4688
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$6K ﹤0.01%
79
-373
-83% -$22.7K
BPYU
4689
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$6K ﹤0.01%
+338
New +$6.18K
INTZ
4690
DELISTED
INTRUSION INC NEW
INTZ
$6K ﹤0.01%
394
-1,187
-75% -$18.1K
ALBT
4691
DELISTED
Avalon GloboCare
ALBT
$5K ﹤0.01%
34
-78
-70% -$12.4K
CLIR icon
4692
ClearSign Technologies
CLIR
$24.3M
$5K ﹤0.01%
98
+77
+367% +$3.64K
FGD icon
4693
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.54B
$5K ﹤0.01%
+196
New +$5.18K
FTK icon
4694
Flotek Industries
FTK
$852M
$5K ﹤0.01%
461
-294
-39% -$3.17K
GLDM icon
4695
SPDR Gold MiniShares Trust
GLDM
$27.5B
$5K ﹤0.01%
+150
New +$5.42K
ORN icon
4696
Orion Group Holdings
ORN
$396M
$5K ﹤0.01%
862
-12,962
-94% -$75.5K
SCHG icon
4697
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$5K ﹤0.01%
+264
New +$4.57K
SCPH
4698
DELISTED
scPharmaceuticals
SCPH
$5K ﹤0.01%
770
-5,079
-87% -$30.6K
SNT
4699
Senstar Technologies
SNT
$38M
$5K ﹤0.01%
1,000
SUB icon
4700
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$5K ﹤0.01%
+43
New +$4.64K

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.